Pentagon awards Glaxo $342 mn contract for COVID vaccines

WAR.WIRE

Pentagon awards Glaxo $342 mn contract for COVID vaccines
Washington, July 30 (AFP) Jul 30, 2020
The Pentagon on Thursday announced a $342 million contract has been awarded to British pharmaceutical giant GlaxoSmithKline to deliver "mass quantities of COVID-19 vaccines" to US troops.

It said GSK was the only company to make a bid for the contract, which will consist of supporting "military locations and personnel throughout the continental US and outside the continental US."

The work will be carried out in North Carolina "with an estimated completion date of Feb. 28, 2021," the Pentagon said.

The US Army will supervise execution of the project.

Maven stays silent after routine pass behind Mars

Sun boundary map tracks shifting Alfven surface over solar cycle

Mission Space to fly second space weather payload with Rogue Space

Molecular contacts push tandem solar cells to 31.4 percent efficiency

Asymmetric side chain design boosts thick film organic solar cell efficiency

New analysis links lead cooled reactor corrosion to steel microstructure

Autonomous DARPA project to expand satellite surveillance network by BAE Systems

Momentus joins US Space Force SHIELD contract vehicle

IAEA calls for repair work on Chernobyl sarcophagus

UAlbany Atmospheric Scientist Proposes Innovative Method to Reduce Aviation's Climate Impact

Digital twin successfully launched and deployed into space

Robots that spare warehouse workers the heavy lifting

All rights reserved. Copyright Agence France-Presse. Sections of the information displayed on this page (dispatches, photographs, logos) are protected by intellectual property rights owned by Agence France-Presse. As a consequence, you may not copy, reproduce, modify, transmit, publish, display or in any way commercially exploit any of the content of this section without the prior written consent of Agence France-Presse.